Tapewire

Nasdaq · USD

KLRS

Kalaris Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6805
SEC CIK
0001754068
Parsed reports
363

Last 12 months

Inside the activity.

2 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 25, 2021 Filed May 27, 2021 20:50 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0000899243-21-020864 · doc4.xml · derivative · entry 3

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-24

F4 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:47 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0000899243-21-020863 · doc4.xml · derivative · entry 1

Bornstein Jeffrey S · CIK 0001579989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-24

F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:47 UTC
Vera JuanDirector
GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0000899243-21-020862 · doc4.xml · derivative · entry 1

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-24

F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:45 UTC
Jovan-Embiricos MoranaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0000899243-21-020859 · doc4.xml · derivative · entry 1

Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-24

F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

Read SEC document
May 18, 2021 Filed Sep 20, 2021 22:33 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 15,201 $22.80 $346,582.80
Disclosure

SEC source: 0000899243-21-036636 · doc4.xml · nonDerivative · entry 3

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457,321

F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.

Read SEC document
May 17, 2021 Filed May 18, 2021 17:08 UTC
Brainard DianaDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $23.74 $0.00
Disclosure

SEC source: 0000899243-21-019779 · doc4.xml · derivative · entry 3

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2031-05-17

F3 · derivative.exercise_date: 25% of this option shall vest and become exercisable on May 17, 2022, with the remainder vesting in twelve quarterly installments thereafter.

Read SEC document
May 17, 2021 Filed May 18, 2021 17:08 UTC
Brainard DianaDirector · Chief Executive Officer
GrantCommon Stock 170,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019779 · doc4.xml · nonDerivative · entry 2

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,300

F2 · shares: The shares reported in this transaction represent RSUs issued under the Plan. 25% of these RSUs shall vest on May 17, 2022, with the remainder vesting in twelve quarterly installmenters thereafter.

Read SEC document
May 17, 2021 Filed May 18, 2021 17:08 UTC
Brainard DianaDirector · Chief Executive Officer
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019779 · doc4.xml · nonDerivative · entry 1

Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,300

F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on May 17, 2022.

Read SEC document
May 10, 2021 Filed May 10, 2021 21:28 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 150,000 $22.75 $3,412,500.00
Disclosure

SEC source: 0001209191-21-031337 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,309,142

F1 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
April 05, 2021 Filed Sep 20, 2021 16:05 UTC
Melian AgustinChief Medical Officer
SaleCommon Stock 18,212 $23.89 $435,084.68
Disclosure

SEC source: 0000899243-21-036577 · doc4.xml · nonDerivative · entry 1

Melian Agustin · CIK 0001818064 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 498,304

F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 16:53 UTC
Melian AgustinChief Medical Officer
SaleCommon Stock 3,750 $25.97 $97,393.50
Disclosure

SEC source: 0001209191-21-022860 · doc4.xml · nonDerivative · entry 1

Melian Agustin · CIK 0001818064 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,516

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.52 to $26.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 21:08 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 3,025 $30.00 $90,750.91
Disclosure

SEC source: 0001209191-21-021808 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,459,142

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.95 to $30.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 11, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 769 $31.63 $24,321.70
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 14

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,164,954

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 11, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 2,308 $31.63 $72,996.73
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 13

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,412,953

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 11, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 3,397 $30.87 $104,875.58
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 12

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,165,723

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 11, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 10,188 $30.87 $314,535.14
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 11

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,415,261

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 300 $32.31 $9,693.51
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 10

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,169,120

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 900 $32.31 $29,080.53
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 9

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,425,449

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 8,418.75 $31.59 $265,973.57
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 8

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,169,420

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 25,256.25 $31.59 $797,920.71
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 7

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,426,349

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 9,467.25 $30.93 $292,806.89
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 6

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,177,838.75

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 28,402.75 $30.93 $878,448.77
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 5

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,451,605.25

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 10,169 $31.70 $322,317.64
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 4

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,187,306

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 30,506 $31.70 $966,921.23
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 3

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,480,008

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 17,480 $31.30 $547,052.33
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 2

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,197,475

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:43 UTC SaleCommon Stock 52,440 $31.30 $1,641,157.00
Disclosure

SEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 1

Wilson John Robert · CIK 0001755569 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,510,514

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 701 $34.40 $24,116.92
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 9

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 818,663

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.01 to $34.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 2,300 $33.31 $76,604.49
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 8

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 819,364

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.90 to $33.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 6,141 $32.19 $197,669.58
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 7

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 821,664

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 15,289 $31.27 $478,074.80
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 6

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 827,805

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.90 to $31.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 23,660 $30.39 $719,034.50
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 5

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 843,094

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 04, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 10,947 $37.41 $409,554.64
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 4

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 866,754

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.07 to $37.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 04, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 8,814 $36.58 $322,404.66
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 3

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 877,701

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.06 to $37.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 04, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 13,876 $35.46 $492,024.92
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 2

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 886,515

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.06 to $36.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 04, 2021 Filed Mar 8, 2021 16:12 UTC SaleCommon Stock 15,961 $34.67 $553,313.60
Disclosure

SEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 1

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 900,391

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.06 to $35.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 03, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 8,500 $38.53 $327,471.85
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 8

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 916,352

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.30 to $38.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 03, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 6,032 $37.73 $227,616.92
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 7

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 924,852

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.29 to $38.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 03, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 3,383 $36.91 $124,861.12
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 6

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 930,884

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.29 to $37.285. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 03, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 7,546 $38.63 $291,517.83
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 9

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,339,928

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.50 to $38.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 03, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 7,142 $38.22 $272,953.67
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 8

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,347,474

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.50 to $38.495. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 03, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 1,300 $37.01 $48,113.52
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 7

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,354,616

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.50 to $37.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 1,614 $39.14 $63,172.77
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 5

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 934,267

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.89 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 7,317 $38.27 $280,016.47
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 4

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 935,881

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.87 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 3,727 $37.35 $139,198.98
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 3

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 943,198

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.845 to $37.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 1,803 $39.10 $70,500.00
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 6

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,355,916

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.84 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 9,001 $38.30 $344,707.70
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 5

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,357,719

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.84 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 4,190 $37.28 $156,188.54
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 4

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,366,720

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.84 to $37.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 02, 2021 Filed Sep 20, 2021 22:33 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 512 $37.93 $19,420.16
Disclosure

SEC source: 0000899243-21-036636 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,522

F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.

F2 · balance_after: As previously reported, the reporting person sold 17,100 shares of Common Stock between February 17, 2021 and March 2, 2021.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 8,869 $39.00 $345,899.87
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 2

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 946,925

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.61 to $39.585. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 20:34 UTC SaleCommon Stock 12,825 $38.39 $492,327.38
Disclosure

SEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 1

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 955,794

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.61 to $38.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.